The US Food and Drug Administration has placed its most serious warning — a so-called black-box warning — on a drug used to ...

The Food and Drug Administration (FDA) has added a boxed warning about liver injury to fezolinetant (Veozah), a drug often ...

AHCC demonstrates potential in preventing liver fibrosis progression by inhibiting HSC activation and regulating key pathways ...

MASLD occurs when excess fat builds up in the liver, leading to inflammation, liver damage, cirrhosis or liver cancer. It is ...

Dec. 13, 2024 — New research highlights the possibility of screening people with type 2 diabetes for liver damage at the same time as they undergo screening for eye ... Microbiome Changes in ...

Chronic liver damage can lead to hepatitis, which causes fibrosis of the liver. This buildup of collagen and other fibrous ...

The FDA has added a boxed warning to the labeling of Veozah, a medication used to treat hot flashes, highlighting a rare but serious risk of liver injury.

It escalated that warning after reviewing the case of a person with blood markers of liver injury who had been taking the medication for about 40 days. After they stopped taking the medication, ...

A new study from the Karolinska Institutet in Sweden has highlighted that screening for eye disease can also detect liver ...

Children’s Hospital Los Angeles team finds biomarker combination that could predict liver fibrosis early enough to reverse ...